Gastric Ulcer, Neurodegenerative Diseases, Osteo Arthritis Knee, Rheumatoid Arthritis, Skin Diseases, Type2diabetes
Conditions
Brief summary
The goal of this observational study is to assess Prakriti & Vikriti in patients visiting OPD of IIISM department, SRM hospital. The main question\[s\] it aims to answer are: * To evaluate Prakriti & Vikriti of patients using Prakriti & Vikriti questionnaire and with digital devices * To correlate the determined Prakriti and Vikriti with the doctor's assessment along with clinical and biochemical parameters Participants will be advised to follow the treating physician's advice on medicines
Detailed description
The Ayurveda is an ancient documented medical system originated in India. The Ayurveda stratified humans into 7 broad categories based on the phenotype features viz. Vata, Pitta, Kapha, Vatapitta, Vatakapha, Kaphapitta and Vatapittakapha Prakriti types. Also, the features of the disease conditions are clearly described based on the predominance of Vata, Pitta and Kapha or its combinations. Presently, the identification of Prakriti type and Vikriti status are basically subjective assessment. This study proposes to integrate the subjective assessment with objective digital signal parameters. This digital signatures would be useful in ML / AI based assessment and prediction of Prakriti type and Vikriti status of the patients.
Interventions
DRUGPersonalized Ayurveda treatment protocol
The treating physician decided and advised personalized Ayurveda treatment protocol based on disease and patient's condition
Sponsors
SRM Medical College Hospital & Research Centre
Ayurai Private Limited
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No
Inclusion criteria
* Patients of various diseases visiting the OPD
Exclusion criteria
* Pregnancy and lactating females
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change from baseline in Complete blood count at 12 week | 12 weeks | complete blood count, which includes red blood cell count, neutrophil count, eosinophil count, basophil count, lymphocyte count, monocyte count, and platelet count is a standard investigation to measure the abnormality in blood cells |
| Serum Urea | 12 weeks | Measures urea, which is a investigation to measure the abnormality in kidney function |
| Serum creatinine | 12 weeks | Measures creatinine, which is a investigation to measure the abnormality in kidney function |
| Lipid Profile | 12 weeks | Lipid profile test includes Total cholesterol, LDL, HDL, Triglycerides, and non-HDL is a investigation to measure the abnormality in lipids |
| Cytokines (TNF- alpha, IFN-gamma, IL-1, IL-4, IL-6, IL-10) | 12 weeks | Cytokines are inflammatory markers, measured to identify treatment effect in inflammation |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Pulse Plethysmography signals (PPG) - Finger PPG sensor | 12 weeks | PPG is measured to identify pulse wave form changes before and after treatment |
Countries
India
Outcome results
None listed